In 2024 alone Freya Biosciences announced a $10 million investment, Kanvas Bio unveiled clinical data on anti-tumoral immunity impact, EnteroBiotix advances cirrhosis, the FDA allowed OpenBiomes FMT investigation to continue, and Nexilico and Siolta Therapeutics enter collaboration for necrotizing enterocolitis. Despite funding challenges in the past few years, as microbiome awareness increases and new preclinical and clinical data emerges, the microbiome community remains committed to proving the microbiome potential to treat patients across many therapeutic areas.

16 (6)

What Was New for 2025

Celebrate the 10th Anniversary Awards

Join us in honoring a decade of groundbreaking achievements in microbiome research with special awards recognizing exceptional contributions and innovations in the field.

Introduce New Speakers

Gain fresh insights from newly added experts representing companies such as PulmobioticsKanvas Biosciences, and Azitra.

Showcase New Companies

Discover the latest advancements from emerging companies like Alveolus BioMicroviable TherapeuticsUnileverMikrobiomikJona, and Nestle Health Science, each presenting their innovative approaches in microbiome research. 

Engage with Investors

Participate in the startup showcase, featuring an expert panel of leading investors and venture capitalists like Seventure Partners and CSB, as they evaluate and support the next generation of microbiome startups. 

Explore the 2025 Event Guide

  • Access the comprehensive 3-day, 2-track, 40+speaker line up and pre-conference day workshops
Screenshot-2025-06-18-161350

Attending Companies Include

12 (2)

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

20 (4)

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

17 (5)

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.